{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:39:19Z","timestamp":1790422759172,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Algerian National Research Program; FNRSDT"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12253-019-00586-4","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T06:36:43Z","timestamp":1549262203000},"page":"715-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast\/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report"],"prefix":"10.1007","volume":"26","author":[{"given":"Chiraz","family":"Mehemmai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-1252","authenticated-orcid":false,"given":"Farid","family":"Cherbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosr","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmoumene","family":"Guedioura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassila","family":"Benbrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabah","family":"Bakour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Abdelhak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"586_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from: \nhttp:\/\/globocan.iarc.fr\n\n. Accessed on 12\/1\/2018"},{"key":"586_CR2","unstructured":"GLOBOCAN (2012) Breast cancer incidence and mortality worldwide, 2012. International agency for research on cancer. \nhttp:\/\/globocan.iarc.fr\/Pages\/fact_sheets_population.aspx\n\n. Accessed 4 Jan 2018"},{"key":"586_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumors. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"586_CR4","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.1073\/pnas.1732912100","volume":"100","author":"C Sotiriou","year":"2003","unstructured":"Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A et al (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 100:10393\u201310398","journal-title":"Proc Natl Acad Sci U S A"},{"key":"586_CR5","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, Panel members (2011) Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast Cancer 2011. Ann Oncol 22:1736\u20131747. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdr304","journal-title":"Ann Oncol"},{"issue":"2","key":"586_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/BD-150398","volume":"35","author":"F Cherbal","year":"2015","unstructured":"Cherbal F, Gaceb H, Mehemmai C, Saiah I, Bakour R, Rouis AO, Boualga K, Benbrahim W, Mahfouf H (2015) Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study. Breast Dis 35(2):95\u2013102. \nhttps:\/\/doi.org\/10.3233\/BD-150398","journal-title":"Breast Dis"},{"issue":"23","key":"586_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, and the BRCA1 and BRCA2 Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H (2017) BRCA1 and BRCA2 cohort consortium. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402\u20132416. \nhttps:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"issue":"2","key":"586_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10549-006-9493-4","volume":"106","author":"D Purnomosari","year":"2007","unstructured":"Purnomosari D, Pals G, Wahyono A, Aryandono T, Manuaba TW, Haryono SJ, van Diest PJ (2007) BRCA1 and BRCA2 germline mutation analysis in the Indonesian population. Breast Cancer Res Treat 106(2):297\u2013304","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"586_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-015-3312-8","volume":"150","author":"C Villarreal-Garza","year":"2015","unstructured":"Villarreal-Garza C, Weitzel JN, Llacuachaqui M, Sifuentes E, Magallanes-Hoyos MC, Gallardo L, Alvarez-G\u00f3mez RM, Herzog J, Castillo D, Royer R, Akbari M, Lara-Medina F, Herrera LA, Mohar A, Narod SA (2015) The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer. Breast Cancer Res Treat 150(2):389\u2013394. \nhttps:\/\/doi.org\/10.1007\/s10549-015-3312-8","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"586_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10549-017-4356-8","volume":"165","author":"XR Yang","year":"2017","unstructured":"Yang XR, Devi BCR, Sung H, Guida J, Mucaki EJ, Xiao Y, Best A, Garland L, Xie Y, Hu N, Rodriguez-Herrera M, Wang C, Jones K, Luo W, Hicks B, Tang TS, Moitra K, Rogan PK, Dean M (2017) Prevalence and spectrum of germline rare variants in BRCA1\/2 and PALB2 among breast cancer cases in Sarawak, Malaysia. Breast Cancer Res Treat 165(3):687\u2013697. \nhttps:\/\/doi.org\/10.1007\/s10549-017-4356-8","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"586_CR11","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.1038\/s41598-018-27315-2","volume":"8","author":"EI Palmero","year":"2018","unstructured":"Palmero EI, Carraro DM, Alemar B et al (2018) The germline mutational landscape of BRCA1 and BRCA2 in Brazil. Sci Rep 8(1):9188. \nhttps:\/\/doi.org\/10.1038\/s41598-018-27315-2","journal-title":"Sci Rep"},{"issue":"28","key":"586_CR12","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1200\/JCO.2018.78.3977","volume":"36","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Walsh T, Gulsuner S, Casadei S, Lee MK, Ogundiran TO, Ademola A, Falusi AG, Adebamowo CA, Oluwasola AO, Adeoye A, Odetunde A, Babalola CP, Ojengbede OA, Odedina S, Anetor I, Wang S, Huo D, Yoshimatsu TF, Zhang J, Felix GES, King MC, Olopade OI (2018) Inherited breast Cancer in Nigerian women. J Clin Oncol 36(28):2820\u20132825. \nhttps:\/\/doi.org\/10.1200\/JCO.2018.78.3977","journal-title":"J Clin Oncol"},{"issue":"9","key":"586_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138453","volume":"10","author":"A Bekada","year":"2015","unstructured":"Bekada A, Arauna LR, Deba T, Calafell F, Benhamamouch S, Comas D (2015) Genetic heterogeneity in Algerian human populations. PLoS One 10(9):e0138453. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0138453","journal-title":"PLoS One"},{"key":"586_CR14","first-page":"1","volume":"34","author":"F Cherbal","year":"2012","unstructured":"Cherbal F, Bakour R, Adane S, Boualga K (2012) BRCA1 and BRCA2 germline mutation spectrum in hereditary breast\/ovarian cancer families from Maghrebian countries. Breast Dis 34:1\u20138","journal-title":"Breast Dis"},{"key":"586_CR15","volume-title":"AJCC Cancer staging manual","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer staging manual, 7th edn. Springer, New York","edition":"7"},{"key":"586_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1200\/JOP.777003","volume":"6","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S (2010) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 6:195\u2013197","journal-title":"J Oncol Pract"},{"key":"586_CR17","doi-asserted-by":"publisher","first-page":"285e6","DOI":"10.1016\/j.breast.2015.01.014","volume":"24","author":"I Pennacchia","year":"2015","unstructured":"Pennacchia I, Carbone A, Di Cerbo A, Vecchio FM, Arena V (2015) 2013 ASCO\/CAP updated guidelines for human epidermal growth factor receptor 2 testing: impact on routine practice. Breast 24:285e6","journal-title":"Breast"},{"key":"586_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1155\/2010\/585278","volume":"28","author":"F Cherbal","year":"2010","unstructured":"Cherbal F, Bakour R, Adane S, Boualga K, Benais-Pont G, Maillet P (2010) BRCA1 and BRCA2 germline mutations screening in Algerian breast\/ovarian cancer families. Dis Markers 28:377\u2013384","journal-title":"Dis Markers"},{"key":"586_CR19","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/humu.20723","volume":"29","author":"S Engert","year":"2008","unstructured":"Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, Hellebrand H, Goecke TO, Kiechle M, Niederacher D, Schmutzler RK, Meindl A (2008) MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 29:948\u2013958","journal-title":"Hum Mutat"},{"issue":"23","key":"586_CR20","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/jnci\/djm203","volume":"99","author":"YC Tai","year":"2007","unstructured":"Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811\u20131814","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"586_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13058-016-0671-y","volume":"18","author":"V Silvestri","year":"2016","unstructured":"Silvestri V, Barrowdale D, Mulligan AM et al (2016) Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the consortium of investigators of modifiers of BRCA1\/2. Breast Cancer Res 18(1):15. \nhttps:\/\/doi.org\/10.1186\/s13058-016-0671-y","journal-title":"Breast Cancer Res"},{"issue":"3","key":"586_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"Ram\u016bnas Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius R (2010) Founder BRCA1\/2mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1, 397\u2013412(3)","journal-title":"EPMA Journal"},{"key":"586_CR23","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","volume":"17","author":"AM Gonzalez-Angulo","year":"2011","unstructured":"Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK, Hortobagyi GN, Do KA, Mills GB, Meric-Bernstam F (2011) Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res 17:1082\u20131089","journal-title":"Clin Cancer Res"},{"key":"586_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/bjc.2012.31","volume":"106","author":"L Robertson","year":"2012","unstructured":"Robertson L, Hanson H, Seal S, Warren-Perry M, Hughes D, Howell I, Turnbull C, Houlston R, Shanley S, Butler S, Evans DG, Ross G, Eccles D, Tutt A, Rahman N, TNT Trial TMG., BCSC (UK) (2012) BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50\u00a0years. Br J Cancer 106:1234\u20131238","journal-title":"Br J Cancer"},{"issue":"5","key":"586_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038361","volume":"7","author":"P Meyer","year":"2012","unstructured":"Meyer P, Landgraf K, H\u00f6gel B, Eiermann W, Ataseven B (2012) BRCA2 mutations and triple- negative breast cancer. PLoS One 7(5):e38361. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0038361","journal-title":"PLoS One"},{"key":"586_CR26","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/cncr.26576","volume":"118","author":"AR Hartman","year":"2012","unstructured":"Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, Griffin M, Hamilton SA, Frye CA, Silberman MA, Wenstrup RJ, Sandbach JF (2012) Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer 118:2787\u20132782","journal-title":"Cancer"},{"key":"586_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2014","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, Janni W, Rack B, Ekici AB, Slamon DJ, Konstantopoulou I, Fostira F, Vratimos A, Fountzilas G, Pelttari LM, Tapper WJ, Durcan L, Cross SS, Pilarski R, Shapiro CL, Klemp J, Yao S, Garber J, Cox A, Brauch H, Ambrosone C, Nevanlinna H, Yannoukakos D, Slager SL, Vachon CM, Eccles DM, Fasching PA (2014) Inherited mutations in 17 breast cancer susceptibility genes among a large triple negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304\u2013311. \nhttps:\/\/doi.org\/10.1200\/JCO.2014.57.1414","journal-title":"J Clin Oncol"},{"key":"586_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10549-015-3293-7","volume":"50","author":"MW Wong-Brown","year":"2015","unstructured":"Wong-Brown MW, Meldrum CJ, Carpenter JE et al (2015) Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Res Treat 50:71\u201380","journal-title":"Breast Cancer Res Treat"},{"key":"586_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000455999","volume":"1","author":"E Hahnen","year":"2017","unstructured":"Hahnen E, Hauke J, Engel C, Neidhardt G, Rhiem K, Schmutzler RK (2017) Germline mutations in triple-negative breast Cancer. Breast Care (Basel) 1:15\u201319. \nhttps:\/\/doi.org\/10.1159\/000455999","journal-title":"Breast Care (Basel)"},{"key":"586_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3389\/fphar.2018.00909","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Wu J, Zhang Z et al (2018) Association between BRCA status and triple-negative breast Cancer: a meta-analysis. Front Pharmacol 9:909. \nhttps:\/\/doi.org\/10.3389\/fphar.2018.00909","journal-title":"Front Pharmacol"},{"issue":"14 Suppl","key":"586_CR31","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1158\/1538-7445.AM2016-2553","volume":"76","author":"F Cherbal","year":"2016","unstructured":"Cherbal F, Gaceb H, Mehemmai C, Bakour R, Yatta K, Boukoufa I, Mahfouf H, Boualga K (2016) Abstract 2553 : prevalence of BRCA1 germline mutations in Algerian population: implications for genetic testing and counseling. Cancer Res 76(14 Suppl):2553. \nhttps:\/\/doi.org\/10.1158\/1538-7445.AM2016-2553","journal-title":"Cancer Res"},{"key":"586_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10038-007-0195-5","volume":"52","author":"W Troudi","year":"2007","unstructured":"Troudi W, Uhrhammer N, Sibille C, Dahan C, Mahfoudh W, Bouchlaka Souissi C, Jalabert T, Chouchane L, Bignon YJ, Ben Ayed F, Ben Ammar Elgaaied A (2007) Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia. J Hum Genet 52:915\u2013920","journal-title":"J Hum Genet"},{"issue":"3","key":"586_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ygyno.2012.03.007","volume":"125","author":"A Tazzite","year":"2012","unstructured":"Tazzite A, Jouhadi H, Nadifi S, Aretini P, Falaschi E, Collavoli A, Benider A, Caligo MA (2012) BRCA1 and BRCA2 germline mutations in Moroccan breast\/ovarian cancer families: novel mutations and unclassified variants. Gynecol Oncol 125(3):687\u2013692. \nhttps:\/\/doi.org\/10.1016\/j.ygyno.2012.03.007","journal-title":"Gynecol Oncol"},{"key":"586_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1471-2407-13-243","volume":"13","author":"P Blay","year":"2013","unstructured":"Blay P, Santamar\u00eda I, Pitiot AS, Luque M, Alvarado MG, Lastra A, Fern\u00e1ndez Y, Paredes \u00c1, Freije JMP, Balb\u00edn M (2013) Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (northern Spain). BMC Cancer 13:243. \nhttps:\/\/doi.org\/10.1186\/1471-2407-13-243","journal-title":"BMC Cancer"},{"issue":"1","key":"586_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/cge.12119","volume":"85","author":"M Krajc","year":"2014","unstructured":"Krajc M, Zadnik V, Novakovi\u0107 S, Stegel V, Teugels E, Be\u0161i\u010d N, Ho\u010devar M, Vakselj A, de Gr\u00e8ve J, \u017dgajnar J (2014) Geographical distribution of Slovenian BRCA1\/2 families according to family origin: implications for genetic screening. Clin Genet 85(1):59\u201363. \nhttps:\/\/doi.org\/10.1111\/cge.12119","journal-title":"Clin Genet"},{"issue":"1","key":"586_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40659-017-0139-2","volume":"50","author":"L Jara","year":"2017","unstructured":"Jara L, Morales S, de Mayo T, Gonzalez-Hormazabal P, Carrasco V, Godoy R (2017) Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in central and south American populations. Biol Res 50(1):35. \nhttps:\/\/doi.org\/10.1186\/s40659-017-0139-2","journal-title":"Biol Res"}],"updated-by":[{"DOI":"10.1007\/s12253-019-00625-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000}}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00586-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00586-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00586-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T07:08:46Z","timestamp":1592291326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00586-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00586-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12253-019-00625-0","asserted-by":"object"}]},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article unfortunately contained an error in the abstract section and Figure 2h image.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare non conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All patients tested for <i>BRCA1<\/i> and <i>BRCA2<\/i> germline mutations and screened by PCR-direct sequencing and NGS analysis, respectively, signed written informed consent. The study was approved by the institutional review boards and ethical approval was obtained from appropriate institutions (USTHB, CAC Batna, FNRSDT and CNEPRU D01N01UN160420130007, 113 participants, start date: 4\/16\/2015, end date: 9\/28\/2016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}